| 产品描述: | Kv2.1-IN-1 is an orally active and blood-brain barrier penetrant Kv2.1 inhibitor with an IC50 of 0.07 μM. Kv2.1-IN-1 exhibits a selectivity >130 fold over other K+, Na+, and Ca2+ ion channels. Kv2.1-IN-1 decreases the apoptosis of HEK293 cells induced by H2O2. Kv2.1-IN-1 produces significant neuroprotection efficacy in middle cerebral artery occlusion (MCAO) rat. Kv2.1-IN-1 can be used for the study of ischemic stroke. |
| 体外研究: |
Kv2.1-IN-1 (Compound 80) (5 mg/kg, p.o. and 1 mg/kg, i.v., 单次给药) 在大脑中的浓度在 30 分钟时约为54.9 ng/g (p.o.),且在 15 分钟和 30 分钟时,大脑中的浓度分别为 38.2 ng/g 和 14.6 ng/g (i.v.)。 Kv2.1-IN-1 (0.3-3 mg/kg, i.v. 和 5 mg/kg, p.o., 单次给药) 在 MCAO 大鼠模型中显示出抗脑梗死功效。 |
| 体内研究: |
Kv2.1-IN-1 (Compound 80) (0.3-3 μM) 显著降低了 H2O2 诱导后的 HEK293 细胞的凋亡率。 |
| 参考文献: |
1. Jie Zhou, et al. Discovery of 2-Ethoxy-5-isobutyramido-N-1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects. J Med Chem. 2023 Dec 27. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.608 ml |
13.038 ml |
26.077 ml |
| 5 mM |
0.522 ml |
2.608 ml |
5.215 ml |
| 10 mM |
0.261 ml |
1.304 ml |
2.608 ml |
| 50 mM |
0.052 ml |
0.261 ml |
0.522 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |